Xenon Pharmaceuticals: 3Q Earnings Snapshot
BURNABY, British Columbia (AP) _ Xenon Pharmaceuticals Inc. (XENE) on Tuesday reported a loss of $8.9 million in its third quarter.
On a per-share basis, the Burnaby, British Columbia-based company said it had a loss of 33 cents.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 49 cents per share.
The gene therapy biotech company posted revenue of $3.5 million in the period.
Xenon Pharmaceuticals shares have climbed 45% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $9.15, a fall of 12% in the last 12 months.